Scientists examined the efficacy of TY101 as an anti-tumor immune reagent combined with HMGN1and R848.
[International Immunopharmacology]
Sorry, but the selected Zotpress account can't be found.
Home Newsletters Immune Regulation News A TNFR2 Antibody by Countering Immunosuppression Cooperates with HMGN1 and R848 Immune...
